Osteonecrosis of the Jaw (ONJ) in Osteoporosis Patients: Report of Delayed Diagnosis of a Multisite Case and Commentary about Risks Coming from a Restricted ONJ Definition
- PMID: 29563419
- PMCID: PMC5806981
- DOI: 10.3390/dj5010013
Osteonecrosis of the Jaw (ONJ) in Osteoporosis Patients: Report of Delayed Diagnosis of a Multisite Case and Commentary about Risks Coming from a Restricted ONJ Definition
Abstract
Osteonecrosis of the jaws (ONJ) in osteoporosis patients has been defined as rare, but the number of reported cases is increasing. We report a case of delayed ONJ diagnosis in a patient, who was being treated with alendronate, developing bone alterations both in maxilla and in mandible. Underestimation of ONJ incidence and missed or delayed ONJ diagnosis in osteoporosis patients might derive from lack of awareness of health providers as well as from an ONJ definition that is too restricted. The more recent definition of medication-related osteonecrosis of the jaws (MRONJ) released in 2014 by the American Association of Oral Maxillofacial Surgeons (AAOMS) accept fistula, besides bone exposure, as a major sign of disease, but it seems to be insufficient since it excludes all cases of ONJ disease without bone exposure. A new MRONJ definition is needed to avoid missing or delayed diagnosis.
Keywords: BRONJ; MRONJ; alendronate; bisphosphonate; laser therapy; osteonecrosis of jaw; osteoporosis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures













Similar articles
-
Medication Related Osteonecrosis of the Jaw: 2015 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons.J Bone Metab. 2015 Nov;22(4):151-65. doi: 10.11005/jbm.2015.22.4.151. Epub 2015 Nov 30. J Bone Metab. 2015. PMID: 26713306 Free PMC article. Review.
-
A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.Clin Ther. 2007 Aug;29(8):1548-58. doi: 10.1016/j.clinthera.2007.08.008. Clin Ther. 2007. PMID: 17919538 Review.
-
Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.J Oral Maxillofac Surg. 2009 Jul;67(7):1363-72. doi: 10.1016/j.joms.2009.03.005. J Oral Maxillofac Surg. 2009. PMID: 19531404
-
Osteonecrosis of jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology.Expert Opin Drug Saf. 2016 Jul;15(7):925-35. doi: 10.1080/14740338.2016.1177021. Epub 2016 May 3. Expert Opin Drug Saf. 2016. PMID: 27074901 Review.
-
Medication Related Osteonecrosis of the Jaw: 2021 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons.J Bone Metab. 2021 Nov;28(4):279-296. doi: 10.11005/jbm.2021.28.4.279. Epub 2021 Nov 30. J Bone Metab. 2021. PMID: 34905675 Free PMC article.
Cited by
-
Medication-Related Osteonecrosis of the Jaw in Dental Practice: A Retrospective Analysis of Data from the Milan Cohort.Dent J (Basel). 2022 May 19;10(5):89. doi: 10.3390/dj10050089. Dent J (Basel). 2022. PMID: 35621542 Free PMC article.
-
Osteonecrosis of the jaw in a patient under treatment of osteoporosis with oral bisphosphonate.Autops Case Rep. 2020 Dec 8;11:e2020186. doi: 10.4322/acr.2020.186. Autops Case Rep. 2020. PMID: 33968812 Free PMC article.
-
Medication-Related Osteonecrosis of the Jaw: A Systematic Review of Case Reports and Case Series.Diseases. 2024 Sep 9;12(9):205. doi: 10.3390/diseases12090205. Diseases. 2024. PMID: 39329874 Free PMC article. Review.
-
Imperatorin promotes osteogenesis and suppresses osteoclast by activating AKT/GSK3 β/β-catenin pathways.J Cell Mol Med. 2020 Feb;24(3):2330-2341. doi: 10.1111/jcmm.14915. Epub 2019 Dec 28. J Cell Mol Med. 2020. PMID: 31883297 Free PMC article.
-
Preventing, identifying, and managing medication-related osteonecrosis of the jaw: a practical guide for nurses and other allied healthcare professionals.Support Care Cancer. 2020 Sep;28(9):4019-4029. doi: 10.1007/s00520-020-05440-x. Epub 2020 Apr 19. Support Care Cancer. 2020. PMID: 32307659 Free PMC article. Review.
References
-
- Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws. J. Oral Maxillofac. Surg. 2007;65:369–376. - PubMed
-
- Khosla S., Burr D., Cauley J., Dempster D.W., Ebeling P.R., Felsenberg D., Gagel R.F., Gilsanz V., Guise T., Koka S., et al. Bisphosphonate-associated osteonecrosis of the jaw: Report of a task force of the American Society for Bone and Mineral Research. J. Bone Miner. Res. 2007;22:1479–1491. doi: 10.1359/jbmr.0707onj. - DOI - PubMed
-
- Ruggiero S.L., Dodson T.B., Assael L.A., Landesberg R., Marx R.E., Mehrotra B., American Association of Oral and Maxillofacial Surgeons American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaw—2009 Update. J. Oral Maxillofac. Surg. 2009;67:2–12. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources